BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 18425881)

  • 21. Choice of intrapleural fibrinolytic agents in the treatment of adult complicated parapneumonic effusion and empyema: Network meta-analysis.
    Yokoyama Y; Kuno T; Takagi H; Burfeind W
    Asian Cardiovasc Thorac Ann; 2023 Jun; 31(5):451-458. PubMed ID: 37287257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrapleural fibrinolytic therapy in complicated parapneumonic effusion and empyema: present status.
    Barthwal MS
    Indian J Chest Dis Allied Sci; 2008; 50(3):277-82. PubMed ID: 18630794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrapleural streptokinase in complicated parapneumonic effusions and empyema.
    Barthwal MS; Deoskar RB; Rajan KE; Chatterjee RS
    Indian J Chest Dis Allied Sci; 2004; 46(4):257-61. PubMed ID: 15515826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical versus non-surgical management of pleural empyema.
    Coote N
    Cochrane Database Syst Rev; 2002; (2):CD001956. PubMed ID: 12076430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A prospective study.
    Misthos P; Sepsas E; Konstantinou M; Athanassiadi K; Skottis I; Lioulias A
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):599-603. PubMed ID: 16129614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local treatment of empyema in children: a systematic review of randomized controlled trials.
    Krenke K; Peradzyńska J; Lange J; Ruszczyński M; Kulus M; Szajewska H
    Acta Paediatr; 2010 Oct; 99(10):1449-53. PubMed ID: 20456264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrapleural Fibrinolytic Therapy for Empyema and Pleural Loculation: Knowns and Unknowns.
    Idell S; Rahman NM
    Ann Am Thorac Soc; 2018 May; 15(5):515-517. PubMed ID: 29361235
    [No Abstract]   [Full Text] [Related]  

  • 28. Intrapleural instillation of fibrinolytic agents for treatment of pleural empyema.
    Cochran JB; Tecklenburg FW; Turner RB
    Pediatr Crit Care Med; 2003 Jan; 4(1):39-43. PubMed ID: 12656540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of complicated parapneumonic pleural effusion with intrapleural streptokinase in children.
    Yao CT; Wu JM; Liu CC; Wu MH; Chuang HY; Wang JN
    Chest; 2004 Feb; 125(2):566-71. PubMed ID: 14769739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early administration of intrapleural streptokinase in the treatment of multiloculated pleural effusions and pleural empyemas.
    Laisaar T; Püttsepp E; Laisaar V
    Thorac Cardiovasc Surg; 1996 Oct; 44(5):252-6. PubMed ID: 8948554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions.
    Chin NK; Lim TK
    Chest; 1997 Feb; 111(2):275-9. PubMed ID: 9041968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefit of intrapleural fibrinolytic therapy in the treatment of complicated parapneumonic effusion and empyema.
    Merhabene T; Zayet S; Jamoussi A; Ayed S; Mansouri S; Khelil JB; Besbes M
    Pan Afr Med J; 2024; 47():54. PubMed ID: 38646137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrapleural streptokinase for empyema and complicated parapneumonic effusions.
    Diacon AH; Theron J; Schuurmans MM; Van de Wal BW; Bolliger CT
    Am J Respir Crit Care Med; 2004 Jul; 170(1):49-53. PubMed ID: 15044206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study.
    Bouros D; Schiza S; Tzanakis N; Chalkiadakis G; Drositis J; Siafakas N
    Am J Respir Crit Care Med; 1999 Jan; 159(1):37-42. PubMed ID: 9872815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of febrinolytic therapy for treatment of pleural infection].
    Jin JM; Sun YC
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):327-9. PubMed ID: 24047804
    [No Abstract]   [Full Text] [Related]  

  • 36. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
    Khemasuwan D; Sorensen J; Griffin DC
    Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions.
    Thommi G; Shehan JC; Robison KL; Christensen M; Backemeyer LA; McLeay MT
    Respir Med; 2012 May; 106(5):716-23. PubMed ID: 22398159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrapleural therapy in management of complicated parapneumonic effusions and empyema.
    Ahmed AH; Yacoub TE
    Clin Pharmacol; 2010; 2():213-21. PubMed ID: 22291507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions.
    Arnold DT; Hamilton FW; Elvers KT; Frankland SW; Zahan-Evans N; Patole S; Medford A; Bhatnagar R; Maskell NA
    Am J Respir Crit Care Med; 2020 Jun; 201(12):1545-1553. PubMed ID: 32069085
    [No Abstract]   [Full Text] [Related]  

  • 40. Surgical versus non-surgical management of pleural empyema.
    Coote N; Kay E
    Cochrane Database Syst Rev; 2005 Oct; (4):CD001956. PubMed ID: 16235291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.